Pharmacogenomic-guided treatment showed age-dependent cognitive benefits in depressive disorder patients.
Can a Cheek Swab Pick the Right Antidepressant for You?
This single-center randomized controlled trial enrolled 843 patients with depressive disorder stratified by age. Pharmacogenomic-guided trea…
A DNA test that guides antidepressant choice lifted mood and sharpened thinking in young patients, but gave almost no brain-function boost t…
Anxiety and depressive symptoms increased among U.S. adults during the COVID-19 pandemic
Anxiety and depression symptoms increased among U.S. adults during the pandemic
An observational study of U.S. adults found the percentage reporting recent anxiety or depressive symptoms increased from 36% to 42% between…
Anxiety and depression symptoms rose among U.S. adults from Aug 2020 to Feb 2021, with biggest jumps in young adults and those with less edu…